Financing channel feed – Endpoints News

Financing channel feed

Quince Therapeutics faces takeover bid from shareholder Echo Lake Capital

3 years ago

A $123M Flare will get Third Rock oncology biotech into the clinic this year

3 years ago

After raising $140M, SPAC will take biotech public with a fraction of planned funds

3 years ago

Karuna to raise $400M in market a day after positive readout of schizophrenia drug

3 years ago

'Very real' headwinds: With leaner staff, cancer vaccine maker searches for help

3 years ago

In ‘surprise’ move, BioXcel files for cancer subsidiary to go public

3 years ago

Medicxi backs siRNA-focused Aldena Therapeutics with $30M

3 years ago

Esperion stock halved after Daiichi discord over $440M heart pill milestones

3 years ago

German biotech launches with ‘seamless’ gene editing platform built on evolving enzymes

3 years ago

German cannabis medicine manufacturer lands $17M+ in funding

3 years ago

Five pharmas back $85M Series A for Mediar's fibrosis-modulating antibodies

3 years ago

Exercise in a pill? That's the focus of Cambrian's new pipeline company

3 years ago

Eli Lilly, UCB and others Switch into gear with $52M for new RNA biotech

3 years ago

Silicon Valley Bank customers to have all funds accessible, US says, easing biotech and tech turmoil

3 years ago

Updated: Worries over Silicon Valley Bank ripple through tech and biotech startups, VCs

3 years ago

Versant's new immunology biotech Santa Ana Bio snags Series A with GV, TPG partners on board

3 years ago

Flagship biotech 'Rings' in $85M+ for next-gen gene therapy effort

3 years ago

ALS biotech QurAlis gets $88M boost from four pharmas for pair of PhI studies

3 years ago

Lenz Therapeutics eyes better vision than AbbVie, Orasis with $80M+ for three PhIII trials

3 years ago

Ampersand snags $50M as Flagship focuses therapeutics on desired targets only

3 years ago

Janssen's neuro division churns out Rapport, a new $100M biotech from Third Rock’s clinical data hunt

3 years ago

Oncology specialist Volastra brings in PhI drug from Amgen, nabs $60M in Series A

3 years ago

Noema Pharma raises $112M Series B to advance CNS disorder pipeline with Roche candidates

3 years ago

Red Tree, RA Capital lead $108M infusion into Bicara and its bifunctional I/O drug

3 years ago

First page Previous page 36 37 383940 41 42 Next page Last page